Rhythm Pharmaceuticals, Inc. (RYTM) KPIs and segments
Close on Nov 13, 2026Market cap $7.92BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Rhythm Pharmaceuticals's business
Rhythm Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product revenue, net($M) | 71.3 | 60.1 | 57.3 | 51.3 | 48.5 | 37.7 | 41.8 | 33.3 | 29.1 | 26.0 | 24.2 | 22.5 | |
License revenue($M) | 0 | 0 | 0 | 0 | 0 | -5.01 | |||||||
United States($M) | 51.0 | 36.9 | 39.0 | 38.2 | 32.0 | 24.4 | 31.7 | 23.3 | 21.6 | 19.4 | 18.3 | 17.9 | |
International($M) | 20.3 | 23.2 | 18.3 | 13.1 | 16.5 | 13.3 | 10.1 | 9.95 | 7.44 | 6.52 | |||
Earlier reporting (last reported 2024)2 | |||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-04.
See a number that looks wrong?